OTCMKTS:ESLOY
EssilorLuxottica (ESLOY)
Financials 
Technical Analysis 
Sep 13, 2026, 12:00 amThis summary was created by AI, based on 2 opinions in the last 12 months.
EssilorLuxottica (ESLOY-OTC) has faced significant stock price declines recently, but analysts maintain a positive outlook due to the increasing demand for eyewear, particularly as an aging population requires vision correction. Moreover, the company stands to benefit from the rising popularity of eyewear as a fashion statement. Despite the broader headwinds from global events, such as the US-Iran conflict affecting luxury markets, experts believe that the company's robust connections, including partnerships with luxury brands like Dior for third-party lenses, position it well for recovery. The stock has gained roughly 48-49% this year and offers a diversified exposure to innovative technology sectors, such as virtual reality—with Essilor providing lenses for META's VR glasses while Luxottica supplies the frames. Given these factors, analysts suggest that the stock may be undervalued, especially with a price target set at $150.00.
Doesn't like META, but a way around that is to own this name instead. Makes the virtual reality glasses for META. Essilor does the lenses, and Luxottica does the frames. Less volatility. Up this year ~48-49%.
Shows that you don't have to own the big names. You can own names that have access to what's happening in AI and virtual reality, diversify your portfolio, and lessen the volatility risk.
David DriscollReally good growth in the business, great demographics. Great European business. Very few competitors. High end.
Paul Harris, CFAIt is a framing business for eye wear. People need more glasses due to so much computer use which can affect the eyes. Also includes frames for fashionable sunglasses etc. There is lots of growth.
Paul Harris, CFAGlasses and frames. Fashion statement plus necessity. Need has gone up as people age and with increased screen use. Grant purchase gave them huge retail presence. Lots of third-party contracts. Tech leader. Large player among a small group. Yield is 1.6%.
Paul Harris, CFALenses plus frames. Lots of third-party business for the likes of Gucci and Armani. Demographic play, plus a fashion play. Screen time has increased need for glasses earlier. Yield is 1.6%.
(Analysts’ price target is $119.37)Paul Harris, CFASo much screen time is deteriorating people's eyesight, so they need glasses. Aging population needs glasses. Fashion statement. Way ahead on technology. Yield is 1.8%.
(Analysts’ price target is $109.40)Paul Harris, CFALenses plus frames. Has a lock on the whole value chain. Purchase of Grant Vision will dramatically change its business over the next several years. Use of lenses has increased because of aging demographics plus faster eye deterioration from computer screens. Also a fashion statement. Great technology. Yield is 1.7%.
(Analysts’ price target is $109.40)Paul Harris, CFAGreat growth from a demographic point of view. Largest player in the world in this area. Almost like an oligopoly, especially in making lenses. Really good lens technology, very innovative. Great story. Buy here and still do well.
Paul Harris, CFAPaul Harris, CFAPaul Harris, CFAPaul Harris, CFAPaul Harris, CFA
Norman LevinePaul Harris, CFA'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Popular Articles
EssilorLuxottica (ESLOY) Frequently Asked Questions
What is EssilorLuxottica stock symbol?
EssilorLuxottica is a American stock, trading under the symbol ESLOY (previously ESLOY-OTC on Stockchase) on the US OTC (ESLOY). It is usually referred to as OTC:ESLOY or ESLOY
Is EssilorLuxottica a buy or a sell?
In the last year, 2 stock analysts issued a Buy, Sell, or Hold rating on ESLOY (previously ESLOY-OTC on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for EssilorLuxottica.
Is EssilorLuxottica a good investment or a top pick?
EssilorLuxottica was recommended as a Top Pick by Paul Harris, CFA on 2026-06-23. Read the latest stock experts ratings for EssilorLuxottica.
Why is EssilorLuxottica stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for EssilorLuxottica.
Is EssilorLuxottica worth watching?
EssilorLuxottica is followed by 33 investors on Stockchase and is a trending stock that is worth watching.
What is EssilorLuxottica stock price?
On 2026-09-10, EssilorLuxottica (ESLOY) stock closed at a price of $84.45.
The stock has fallen a lot. The use of glasses has risen a lot as people age, and as eyewear becomes fashionable. Luxury stocks fell with the US-Iran war, but things will rebound. They make third-party lenses for people like Dior. Is trading cheaply now.
(Analysts’ price target is $150.00)